Women have been historically underrepresented in clinical trials for cardiovascular diseases, leading to a gap in knowledge about how heart disease manifests and progresses in women. This lack of representation translates into prevention, diagnosis, and treatment strategies that are not fully optimized for women's health needs.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.